Warfarin Sodium, amorphous

Warfarin Sodium, amorphous; API; EP, USP, JP, ANVISA; [129-06-6]


Warfarin Sodium, amorphous is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads [129-06-6]. It is used to treat or prevent blood clots in veins or arteries, which can reduce the risk of stroke, heart attack, or other serious conditions. Detailed specification, Certificate of Analysis and samples are available on request. Warfarin sodium is a 4-hydroxycumarin, these are known as vitamin K antagonists. Vitamin K antagonists are anticoagulants that encroach on the blood clotting cascade. Since the substance can have significant fluctuations in its effectiveness, depending on the genotype, the blood clotting levels for dose tuning should be tested regularly.

Pharmaceutical products
  • warfarin
  • anticoagulant
  • heart attack

Product features

CAS 129-06-6
Product Information API
Route of Synthesis Synthetic
Patent Expiry EU, US - expired
Indication Anticoagulant, Tromboembosism
Dosage Oral and iv formulation

Other products from this business